The study analyzed 24-month health plan costs associated with treating urinary incontinence in adult women receiving usual care, or CCP, compared to women using Leva as a first-line treatment for UI.

NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc. (Axena Health), a medical device company relentlessly dedicated to women’s health, today announced that Cigna Healthcare (Cigna), one of the largest ...

NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc. (Axena Health), a women’s health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive ...

The MarketWatch News Department was not involved in the creation of this content. New Budget Impact Model Published in the Journal of Medical Economics Highlights Significant Health Plan Cost Savings ...